FluxMPS™ RPMI 1640 Medium w/o Sodium Bicarbonate: 1X Liquid

Product#: DCP-RPMI-B1X
$34.10
DCP-RPMI-B1X
Availability:
Ships in 1-2 Weeks

warning For Research Use Only (RUO). Not intended for clinical, diagnostic, or therapeutic use in humans.
verified ISO 13485 Certified Manufacturing

FluxMPS™ RPMI 1640 Medium w/o Sodium Bicarbonate: 1X Liquid

Contains L-Glutamine Contains Phenol Red Contains Calcium Contains Magnesium Contains 2.0 g/L Glucose Contains Sodium Pyruvate Without Sodium Bicarbonate

FluxMPS™ DCP-RPMI-B1X is a Microfluidics Suitable, quadruple-stage ultra-filtered RPMI 1640 formulation without sodium bicarbonate, engineered for hematopoietic cells, lymphocytes, and related immune-cell models on microfluidic, organ-on-a-chip (OoC) and microphysiological system (MPS) platforms. A quadruple-stage filtration train (0.1 µm ×2 + 0.04 µm ×2) reaches a 0.04 µm final cut-off — five times finer than the 0.22 µm membranes used for conventional sterile filtration. Formulation: [+] L-Glutamine, [+] Phenol Red, [+] Calcium, [+] Magnesium, [+] 2.0 g/L Glucose, [+] Sodium Pyruvate | [-] Sodium Bicarbonate.

  • Glucose source: 2000 mg/L (2.0 g/L) D-Glucose — standard RPMI 1640 carbon source, ready for lymphocyte and hematopoietic cell culture
  • L-Glutamine included at 300 mg/L for direct nitrogen and energy metabolism — no re-supplementation required at time of use
  • Sodium bicarbonate excluded — CO₂-independent formulation; buffer with HEPES (10–25 mM) for atmospheric (non-CO₂) culture systems
  • Glutathione (reduced), 1.0 mg/L — antioxidant support for redox-sensitive lymphocyte and hematopoietic cell types
  • Quadruple-stage filtration train (0.1 µm ×2 + 0.04 µm ×2) reaching a 0.04 µm final cut-off, five times finer than 0.22 µm conventional filtration
  • Endotoxin release specification < 0.05 EU/mL (LAL assay, USP <85>), verified per manufacturing batch prior to release
  • Manufactured under an ISO 13485:2016 quality management system; final QC at Diagnocine, Totowa, NJ
  • Custom pH, nutrient concentration, and HEPES supplementation available on request — contact support@diagnocine.com
CAT. NO.
DCP-RPMI-B1X | Cell Culture Media UNSPSC: 41116155 | Commodity: Molecular biology and cell culture growth media | (UNv260801)
RPMI 1640 w/o Sodium Bicarbonate — 1X Liquid
  • Media familyRPMI 1640
  • Glucose2000 mg/L (2.0 g/L)
  • Formulation[+] L-Glutamine, [+] Phenol Red, [+] Calcium, [+] Magnesium, [+] 2.0 g/L Glucose, [+] Sodium Pyruvate | [-] Sodium Bicarbonate
  • AppearanceOrange-red, clear solution (phenol red present)
  • pH (USP <791>)7.4
  • Osmolality (USP <785>)230–270 mOsm/kg H₂O
  • Endotoxin (USP <85>)< 0.05 EU/mL
  • Filtration0.1 µm ×2 + 0.04 µm ×2
  • Storage2–8°C, protect from light
  • Shelf Life12 months from date of manufacture, unopened
ISO 13485:2016 USP <85> <785> <788> RUO
Why FluxMPS™

Engineered where standard media fails

Conventional 0.22 µm–filtered RPMI passes mycoplasma-sized organisms, subvisible particulates, and endotoxin fragments that activate TLR4 signaling and confound immune cell assays. FluxMPS™ is built to address these failure modes at the filtration level.

filter_alt

Microchannel-safe purity

0.04 µm final filtration with USP <788> Method 1 (light obscuration) particulate compliance — particle-controlled media for suspension immune cell OoC and flow cytometry.

science

Immune cell–optimized formulation

RPMI 1640 contains glutathione (antioxidant) and a balanced profile of vitamins and amino acids formulated for lymphocyte and hematopoietic cell culture.

water_drop

Ultrapure-grade water

Type 1 water, 18.2 MΩ·cm resistivity; trace-metal and organic-carbon (TOC) controlled for consistent lot-to-lot formulation.

shield

Low endotoxin release specification

< 0.05 EU/mL release specification — reduces the risk of LPS-driven TLR4 activation artifacts that can confound lymphocyte and NK cell assays.

analytics

Rich nutrient profile

RPMI 1640's specialized nutrient set, including glutathione and a full amino acid/vitamin profile, is delivered through a particulate-controlled 0.04 µm filtration train suited to OoC use.

tune

Customization on demand

pH, nutrient concentrations, HEPES, and component modifications available. Contact support@diagnocine.com.

Purity Architecture

Quadruple-stage filtration system

Four serial filtration passes — two dedicated prefilter + final-filter pairs — reaching a final 0.04 µm polish under ISO Class 5 aseptic conditions.

  1. 1

    0.1 µm Prefiltration I

    Removes large particulates, cell debris and protein aggregates; the 0.1 µm mycoplasma-retentive grade membrane protects the downstream 0.04 µm cartridge.

  2. 2

    0.04 µm Final filtration I

    First 0.04 µm pass; retains sub-micron particulates and microaggregates below the resolution of conventional 0.22 µm filtration.

  3. 3

    0.1 µm Prefiltration II

    Second dedicated 0.1 µm mycoplasma-retentive prefilter, protecting the second 0.04 µm cartridge.

  4. 4

    0.04 µm Final filtration II — Polish

    Ultimate 0.04 µm polishing filter; aseptic fill & finish.

Performance vs. conventional media

FluxMPS™ DCP-RPMI-B1X is processed through a quadruple-stage filtration train (0.1 µm ×2 + 0.04 µm ×2) reaching a 0.04 µm final cut-off — five times finer than the 0.22 µm membranes used for conventional sterile filtration — with a dedicated 0.1 µm mycoplasma-retentive prefilter ahead of every 0.04 µm final filter.

4
Sequential filtration passes (0.1 µm ×2 + 0.04 µm ×2)
0.04
µm final pore size — five times finer than 0.22 µm conventional filtration
Sterility & Mycoplasma: No growth after 14-day incubation (USP <71>). Mycoplasma risk is mitigated via 0.1 µm mycoplasma-retentive filtration at every production stage (not tested per lot).
Grade: This product is Microfluidics Suitable, filtered to a 0.04 µm final cut-off. It is not an MPS Grade product — that designation is reserved for the 0.01 µm ultra nano-filtered line, which adds 0.02 µm and 0.01 µm stages after the 0.04 µm polish. For applications requiring the 0.01 µm cut-off, contact support@diagnocine.com.
FluxMPS DCP-RPMI-B1X RPMI 1640 without sodium bicarbonate quadruple-stage filtration system 0.1 micron x2 plus 0.04 micron x2 for organ-on-a-chip and microfluidic hematopoietic cell culture, Diagnocine
Figure 1. FluxMPS™ Quadruple-stage filtration system (0.1 µm ×2 + 0.04 µm ×2).
© Diagnocine® — DCP-RPMI-B1X
Applications

Immune cell OoC and hematopoietic applications

FluxMPS™ DCP-RPMI-B1X — RPMI 1640 without sodium bicarbonate — delivers 0.04 µm filtered purity for hematopoietic cells, lymphocytes and related OoC applications.

Automated Bioreactors & Robotics

Next-Generation System Uptime

An optional 0.01 µm (10 nm) ultra nano-filtered MPS Grade variant of this formulation is available on request for automated perfusion systems.

  • Total Particulate Exclusion: 10 nm filtration removes nanoparticulate aggregates
  • Valve & Sensor Protection: Eliminates micro-fouling in automated perfusion systems
  • Extended Perfusion Stability: Consistent nutrient delivery over long-duration culture

Inquiry Required: Contact support@diagnocine.com for the 0.01 µm MPS Grade variant.

Immunology

T Cell & Lymphocyte Culture

RPMI 1640 is the standard base for primary T cells, B cells, NK cells, and monocytes. The 0.04 µm filtration reduces particulate load that can confound TLR4-mediated immune assays.

T cellsB cellsNK cellsPBMC
Cancer Biology

Leukemia & Lymphoma Lines

RPMI supports NCI-60 hematopoietic cancer lines, Jurkat, Raji, K562, and HL-60 — lines where DMEM would alter proliferation and signaling.

JurkatRajiK562HL-60
Microfluidics

Immune Cell OoC

0.04 µm filtered RPMI for tumor-immune interaction chips, vascular-immune OoC, and lymph node-on-chip models built on microphysiological system (MPS) platforms.

Tumor-immune chipLymph node OoCMPS
Immunotherapy

CAR-T & TIL Expansion

Low endotoxin release specification (<0.05 EU/mL) supports CAR-T manufacturing and TIL expansion protocols sensitive to LPS-driven activation artifacts.

CAR-TTILTCR-T
Metabolomics

Immune Cell Metabolic Flux

Defined RPMI base for glycolysis stress tests and ¹³C isotope tracing of lymphocyte activation states. Not compatible with Agilent Seahorse XF assays, which require bicarbonate-free, phenol red-free medium — this formulation contains phenol red.

¹³C tracingGlycolysis
Live-Cell Imaging

Flow Cytometry & Confocal

Ultra-low particulate 0.04 µm filtration for flow cytometry and confocal imaging workflows. Available as a custom phenol red-free formulation on request to eliminate autofluorescence for PE-channel flow cytometry — contact support@diagnocine.com.

Flow cytometryConfocalELISA
Technical Specifications

Analytical release specifications

Every lot released against the full specification matrix. CoA available at support@diagnocine.com.

Physical & Chemical Parameters
Parameter Specification
Formulation [+] L-Glutamine, [+] Phenol Red, [+] Calcium, [+] Magnesium, [+] 2.0 g/L Glucose, [+] Sodium Pyruvate | [-] Sodium Bicarbonate
Appearance Orange-red, clear solution (phenol red present)
Glucose 2000 mg/L (2.0 g/L)
pH USP <791> 7.4
Osmolality USP <785> 230–270 mOsm/kg H₂O
Total ingredients 40
Sterility, Purity & Safety Parameters
Parameter Specification
Endotoxin USP <85> BET < 0.05 EU/mL
Sterility USP <71> No growth / 14 days
Mycoplasma 0.1 µm mycoplasma-retentive filtration (not tested per lot)
Particulate ≥10 µm USP <788> Method 1 NMT 25/mL
Particulate ≥25 µm USP <788> Method 1 NMT 3/mL
Water purity Type 1, 18.2 MΩ·cm
Manufacturing std. ISO 13485:2016
Fill environment ISO Class 5 (Class 100)
Storage, Handling & Logistics
Parameter Specification
Storage temperature 2–8°C, protect from light
Freeze-thaw Do not freeze
Shelf life 12 months from date of manufacture, unopened
Shipping condition Cold pack
CO₂ requirement CO₂-independent; supplement with HEPES (10–25 mM) for pH buffering in atmospheric (non-CO₂) culture
Available sizes 500 mL, 1000 mL
Raw Materials & Regulatory Traceability
Parameter Specification
Raw material grade Reagent / cell culture grade
Traceability Full lot traceability per ISO 13485
Manufacturing QMS ISO ISO 13485:2016 certified
UNSPSC 41116155 — Molecular biology and cell culture growth media (UNv260801)
Regulatory alignment 21 CFR Part 820 (QMSR) aligned
Production method Micro-batch, per-lot QC release
Intended use Research Use Only (RUO)
Formulation

Full composition (mg/L)

RPMI 1640: 40 ingredients verified per lot with CAS numbers for full raw-material traceability. Contains glutathione (antioxidant) and a balanced profile of vitamins and amino acids formulated for lymphocyte and hematopoietic cell culture.

Component CAS Number mg/L
INORGANIC SALTS
Calcium nitrate tetrahydrate 13477-34-4 100.000
Magnesium sulfate anhydrous 7487-88-9 48.840
Potassium chloride 7447-40-7 400.000
Sodium chloride 7647-14-5 6000.000
Sodium phosphate dibasic anhydrous 7558-79-4 800.000
Component CAS Number mg/L
AMINO ACIDS
Glycine 56-40-6 10.000
L-Arginine hydrochloride 1119-34-2 241.000
L-Asparagine 70-47-3 50.000
L-Aspartic acid 56-84-8 20.000
L-Cystine dihydrochloride 30925-07-6 65.200
L-Glutamic acid 56-86-0 20.000
L-Glutamine 56-85-9 300.000
L-Histidine hydrochloride monohydrate 5934-29-2 20.960
L-Hydroxyproline 51-35-4 20.000
L-Isoleucine 73-32-5 50.000
L-Leucine 61-90-5 50.000
L-Lysine hydrochloride 657-27-2 40.000
L-Methionine 63-68-3 15.000
L-Phenylalanine 63-91-2 15.000
L-Proline 147-85-3 20.000
L-Serine 56-45-1 30.000
L-Threonine 72-19-5 20.000
L-Tryptophan 73-22-3 5.000
L-Tyrosine Disodium Salt 69847-45-6 28.830
L-Valine 72-18-4 20.000
Component CAS Number mg/L
VITAMINS
Choline chloride 67-48-1 3.000
D-Biotin 58-85-5 0.200
D-Ca-Pantothenate 137-08-6 0.250
Folic acid 59-30-3 1.000
Niacinamide 98-92-0 1.00
Pyridoxine hydrochloride 58-56-0 1.00
Riboflavin 83-88-5 0.200
Thiamine hydrochloride 67-03-8 1.000
Vitamin B12 68-19-9 0.005
i-Inositol 87-89-8 35.000
p-Amino benzoic acid (PABA) 150-13-0 1.000
OTHERS
D-Glucose 50-99-7 2000.000
Glutathione reduced 70-18-8 1.000
Phenol red sodium salt 34487-61-1 5.300
Sodium pyruvate 113-24-6 110.000
Custom formulation: Contact support@diagnocine.com for DCP-RPMI-B1X modifications.
Quality Assurance

Manufacturing & compliance

Every FluxMPS™ product is manufactured and released under a multi-layer quality system.

verified

ISO 13485:2016 Quality Management

Manufactured under an ISO 13485:2016-certified quality management system. Final QC at Diagnocine R&D Center, Totowa, NJ, USA.

water_drop

Ultrapure Type 1 Water

18.2 MΩ·cm resistivity; trace-metal and organic-carbon (TOC) controlled.

biotech

ISO Class 5 Fill & Finish

Aseptic fill in validated ISO Class 5 (Class 100) laminar-flow workstations.

assignment

Micro-Batch Precision

Small-batch, per-lot tested — no blending; Certificate of Analysis available for every lot.

Endotoxin — USP <85> BET

LAL assay; release specification < 0.05 EU/mL per manufacturing batch.

Particulate — USP <788> Method 1

Light obscuration; NMT 25/mL (≥10 µm), NMT 3/mL (≥25 µm).

Osmolality — USP <785>

Target: 230–270 mOsm/kg H₂O.

Documentation & CoA

Full CoA with raw-material traceability available on request.

Batch-level quality control. Endotoxin is controlled per manufacturing batch rather than per unit. Every batch is tested before release and must meet the release specification:
  • Endotoxin — LAL assay, USP <85> Bacterial Endotoxins Test; assay sensitivity 0.005 EU/mL; release specification < 0.05 EU/mL
  • pH, osmolality, conductivity, appearance and clarity
  • Sterility
A Certificate of Analysis is available on request at support@diagnocine.com.
Product Comparison

How DCP-RPMI-B1X compares

FluxMPS™ DCP-RPMI-B1X vs. conventional 0.22 µm–filtered RPMI formulations.

Parameter DCP-RPMI-B1X (FluxMPS™) Conventional RPMI 1640
(0.22 µm filtered)
Standard DMEM/RPMI
(0.22 µm filtered)
Grade Microfluidics Suitable (0.04 µm) Not applicable Not applicable
RPMI 1640 without Sodium Bicarbonate — CO₂-independent lymphocyte culture; add HEPES for atmospheric incubation check_circle Yes cancel No cancel No
Final filtration pore size 0.04 µm 0.22 µm 0.22 µm
Number of filtration stages 4 (Quadruple) 1 1
Mycoplasma-retentive filtration check_circle Yes (0.1 µm stage) cancel No cancel No
Endotoxin (release specification) FluxMPS™ — < 0.05 EU/mL Corning classical liquid media — < 0.25 EU/mL
Sigma-Aldrich DMEM complete medium — ≤ 2 EU/mL
Gibco classical DMEM — Not specified (recorded per lot)
USP <788> Method 1 particulate tested check_circle Yes cancel No cancel No
Water quality Type 1, 18.2 MΩ·cm Purified water Purified water
Manufacturing QMS ISO 13485:2016 ISO 9001 or none ISO 9001 or none
Microfluidic channel compatible check_circle Yes — Microfluidics Suitable cancel Risk of clogging cancel Risk of clogging
Custom formulation check_circle Yes cancel No cancel No

Comparison figures from published supplier specifications, accessed 2026-09-02. Suppliers that publish no numeric endotoxin specification are shown as "Not specified".

FAQ

Frequently asked questions

Common questions about FluxMPS™ DCP-RPMI-B1X — RPMI 1640 w/o Sodium Bicarbonate.

Yes. DCP-RPMI-B1X is processed through a quadruple-stage filtration train (0.1 µm ×2 + 0.04 µm ×2) reaching a 0.04 µm final cut-off — five times finer than the 0.22 µm membranes used for conventional sterile filtration. RPMI 1640 filtered to this level is suited to immune cell OoC, tumor-immune interaction chips, and lymphocyte perfusion models on microfluidic and microphysiological system (MPS) platforms.
FluxMPS™ uses four sequential passes — 0.1 µm Prefiltration I, 0.04 µm Final filtration I, a second dedicated 0.1 µm Prefiltration II, and 0.04 µm Final filtration II (Polish) — reaching a 0.04 µm final cut-off, five times finer than the 0.22 µm membranes used in conventional filtration, with a dedicated 0.1 µm mycoplasma-retentive prefilter ahead of every 0.04 µm final filter.
Sodium bicarbonate is removed to enable CO₂-independent culture via HEPES (10–25 mM). This is useful for suspension lymphocyte assays in atmospheric environments, flow cytometry preparation outside incubators, and multi-well immune cell assays where CO₂ control is impractical. L-Glutamine, sodium pyruvate and glucose remain in the formulation and do not require re-supplementation.
No. DCP-RPMI-B1X is CO₂-independent; supplement with HEPES (10–25 mM) for pH buffering in atmospheric (non-CO₂) culture systems.
Yes. FBS (5–10%), serum-free supplements, growth factors, or antibiotics can be added as required. Serum and protein-containing additions should be pre-filtered through a 0.2 µm low-protein-binding PES or PVDF membrane before addition — never a 0.04 µm membrane, which retains IgM, VLDL, and much of the lipid/lipoprotein fraction of serum. Contact support@diagnocine.com for custom co-formulation.
FluxMPS™ DCP-RPMI-B1X is produced to meet a release specification of < 0.05 EU/mL by LAL assay (USP <85>), tested per manufacturing batch rather than per unit. For immune cell assays, elevated endotoxin can activate TLR4/NF-κB signaling and alter lymphocyte activation state independently of experimental conditions, which is why a low release specification matters for this application.
Yes. A full CoA per batch covers: appearance, pH (USP <791>), osmolality (USP <785>), sterility (USP <71>), endotoxin (USP <85>), mycoplasma filtration status, particulate count (USP <788> Method 1), lot number, expiry, and raw-material traceability. Request at support@diagnocine.com.
Scientific References

Supporting literature

Key publications supporting RPMI 1640 in immune cell culture and organ-on-a-chip applications.

  1. Moore GE, et al. Culture of normal human leukocytes. JAMA. 1967;199:519–524. doi:10.1083/jcb.1.3.273
  2. Huh D, et al. Reconstituting organ-level lung functions on a chip. Science. 2010;328:1662–1668. doi:10.1126/science.1188302
  3. Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014;32:760–772. doi:10.1038/nbt.2989
  4. Novak R, et al. Robotic fluidic coupling and interrogation of multiple vascularized organ chips. Nat Biomed Eng. 2020;4:407–420. doi:10.1038/s41551-019-0497-x
  5. Jang KJ, et al. Human kidney proximal tubule-on-a-chip. Integr Biol. 2013;5:1119–1129. doi:10.1039/c3ib40049b
  6. Schimek K, et al. Integrating biological vasculature into a multi-organ-chip microsystem. Lab Chip. 2013;13:3588–3598. doi:10.1039/c3lc50217a
  7. Luni C, et al. High-efficiency cellular reprogramming with microfluidics. Nat Methods. 2016;13:446–452. doi:10.1038/nmeth.3832
  8. Sung JH, et al. Microfabricated mammalian organ systems. Lab Chip. 2013;13:1201–1212. doi:10.1039/c3lc41017j

Satisfaction
Quality Rating
Value Rating
Style Rating
X